High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

Abstract

UBD may play an important role in epirubicin resistance in TNBC. UBD has the potential to be a novel biomarker in TNBC chemoresistance and may be a promising therapeutic target for TNBC patients.